Company Research Report: SeqBiome
Company Overview
- Name: SeqBiome
- Mission: To measure, analyse, and interpret the microbiome using state-of-the-art molecular tools, providing customers with meaningful, actionable insights into microbiome.
- Founded: 2020
- Founders: No information is available
- Key People:
- Chief Executive Officer: Prof Marcus Claesson
- Chief Technical Officer: Prof Paul Cotter
- Chief Commercial Officer: Brad Wrigley
- Head of Business Development: David Corr
- Board Member: Frank Walsh
- Operations Manager: Dr Ciara O’Donovan
- Bioinformatician: Marcus O’Brien
- Senior Bioinformatician: Dr Shriram Patel
- Laboratory Technicians: Ramya Balasubramanian, Emmanuel Osei, Laura Finnegan, Vinicius Pedrosa
- Scientific Advisors: Dr Fiona Crispie, Dr Orla O’Sullivan
- Headquarters: Moorepark Food Research Centre, Teagasc, Fermoy, County Cork, P61 C996, Ireland
- Number of Employees: 11-50 employees
- Revenue: No information is available
- Known For: Providing first-in-class technical and scientific microbiome services across various sectors including Nutrition, Pharmaceutical, Beauty, Healthcare, Sport, and Academia.
Products
Solutions Offered
Study Design
- Description: Advice on cutting-edge design procedures with considerations for technical and biological replicates, appropriate sample sizes, sequencing depth, and potential confounders, among others.
- Key Features:
- State-of-the-art experimental design procedures
- Control for fundamental problems in microbiome data
- Foundation for analysis including time series and multi-omics data
Sample Processing
- Description: Customized methodologies considering varying sampling methods, storage, DNA/RNA extraction, and sequencing protocols.
- Key Features:
- Proprietary methodologies for best outcomes
- Detailed advice on sampling variables
Sequencing
- Description: Experience with multiple major platforms, offering 16S rRNA or custom amplicons, shallow and deep shotgun sequencing of metagenomes and metatranscriptomes.
- Key Features:
- Positive and negative controls
- Method of sequencing tailored to answer specific research questions
Compositional and Functional Microbiome Analysis
- Description: Extensive profiling of microbiome composition and function, leveraging phylogenetic markers, and shotgun meta-genomic/transcriptomic sequencing.
- Key Features:
- Custom pipelines for species-level classification
- Compositionally appropriate data analysis and statistical comparison
Biostatistical and Bioinformatic Analysis
- Description: Comprehensive microbiome services with adaptable workflows, from quality control to advanced analysis.
- Key Features:
- Cloud-based scalable bioinformatics pipelines
- State-of-the-art methodologies including contamination checking and advanced statistical modeling
Publication/Patent Ready Outputs
- Description: Tailored outputs focused on clear communication of results, suitable for publication in peer-reviewed journals.
- Key Features:
- High-impact research presentation
- Interactive project engagement
Recent Developments
- SeqBiome expert microbiome analysis partner on the first placebo-controlled trial of vaginal microbiota transplantation (VMT) (July 4, 2024): Partnered with Atlantia Clinical Trials and Freya Biosciences to develop interventions for women's health concerning vaginal microbiota.
- SeqBiome at Probiota Milan 2024 (February 8, 2024): Participation in the leading microbiome industry event hosted by NutraIngredients, represented by Head of Business Development David Corr.
- Joint publication with Roche on microbiome links with diabetes and cancer immunotherapy (January 15, 2024): Co-authored a publication in Immuno Horizons exploring significant links between microbiome, diabetes, and cancer immunotherapy.
- Benefits of fermented foods reviewed in Nature journal (January 15, 2024): CTO Prof Paul Cotter was senior author on a publication in Nature Reviews Gastroenterology discussing benefits of fermented foods.
- Sponsorship of Boston conference (November 10, 2023): CEO Marcus Claesson presented research on the gut microbiome at a Boston conference.
- Microbiome and performance discussion with Real Madrid (September 6, 2023): CTO Paul Cotter discussed the gut microbiome's role in athlete performance at an event with Abbott-Nutrition and Real Madrid CF.
SeqBiome has shown a strong recent track record of leadership in microbiome analysis and research, evident from their participation in significant studies and respected industry events.